Media Center
- No
-
Category
- Show all
- Press Release
- News Article
- PR Video
- CEO Story
- Title
- Author
- Time uploaded
- Views
- Likes
- 166
- Press Release
- Press Release PharmAbcine to participate in Jefferies Global Healthcare Conference and BIO International Convention
- PharmAbcine
- 12 May 2022
- Views1367
- 0
- 165
- Press Release
- Press Release PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study
- PharmAbcine
- 27 Apr 2022
- Views1335
- 0
- 164
- Press Release
- Press Release PharmAbcine Strengthens Scientific Advisory Board with a World-Renowned Expert in Ophthalmology
- PharmAbcine
- 27 Apr 2022
- Views1245
- 0
- 163
- Press Release
- Press Release PharmAbcine Presents Updated Preclinical Data of Its Anti-VISTA Antibody Candidate at AACR 2022
- PharmAbcine
- 12 Apr 2022
- Views2916
- 0
- 162
- CEO Story
- CEO Story PharmAbcine to participate in BIO-Europe Spring 2022
- PharmAbcine
- 17 Mar 2022
- Views1017
- 0
- 161
- Press Release
- Press Release PharmAbcine to Present Updated Data of Its Anti-VISTA Antibody Candidate at AACR 2022
- PharmAbcine
- 9 Mar 2022
- Views1084
- 0
- 160
- Press Release
- Press Release PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial
- PharmAbcine
- 27 Feb 2022
- Views1666
- 0
- 159
- PR Video
- PR Video Biotech Showcase 2022
- PharmAbcine
- 3 Feb 2022
- Views1404
- 0
- 158
- PR Video
- PR Video Access China Biotech Forum Winter Showcase 2022
- PharmAbcine
- 28 Jan 2022
- Views1038
- 0
- 157
- Press Release
- Press Release PharmAbcine Announces First Patient Enrolled and Dosed in the Phase II Clinical Trial for the Treatment of mTNBC
- PharmAbcine
- 28 Dec 2021
- Views1581
- 0